Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis.
Sobhan HaghaniNida Jamali-RaeufyMotahareh ZeinivandSoraya MehrabiLeila AryanJavad Fahanik BabaeePublished in: Basic and clinical neuroscience (2021)
Epilepsy is known as a disorder of the CNS which is caused by an imbalance in the electrical activity of neurons that in turn results in derangement in cognitive or causing debilitating seizures. Hepatocyte growth factor is one of neurotrophins secreted from mesenchymal and epithelial cells that regulate the growth, survival and functional changes of cells through signaling pathways such as the tyrosine kinase pathway after binding to its specific receptor. In this study, we tried to find out the effect of hepatocyte growth factor on attenuation of the severity of status epilepticus in kainic acid-induced model of temporal lobe epilepsy. Our results show that hepatocyte growth factor is able to protect against progression of the kainate-induced temporal lobe epilepsy in rats by improvement of learning, cognitive disturbances and inhibiting of apoptosis and astrogliosis.
Keyphrases
- growth factor
- temporal lobe epilepsy
- cell cycle arrest
- tyrosine kinase
- liver injury
- induced apoptosis
- endoplasmic reticulum stress
- signaling pathway
- drug induced
- pi k akt
- cell death
- oxidative stress
- epidermal growth factor receptor
- stem cells
- high glucose
- bone marrow
- spinal cord
- living cells
- endothelial cells
- binding protein